Liquidia Corp
(NAS:LQDA)
$
12.31
0.08 (0.65%)
Market Cap: 940.66 Mil
Enterprise Value: 779.91 Mil
PE Ratio: 0
PB Ratio: 10.89
GF Score: 73/100 - Q1 2024 Liquidia Corp Earnings Call TranscriptMay 14, 2024$11.96 (-1.48%)Earnings
- Q4 2023 Liquidia Corp Earnings Call TranscriptMar 13, 2024$14.73 (+5.36%)Earnings
- Liquidia Corp at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Liquidia Corp Earnings Call TranscriptNov 07, 2023$6.8 (+3.66%)Earnings
- Q2 2023 Liquidia Corp Earnings Call TranscriptAug 10, 2023$7.89 (+3.14%)Earnings
- Liquidia Corp Corporate Call TranscriptJun 28, 2023
- Liquidia Corp at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Liquidia Corp Earnings Call TranscriptMay 04, 2023$7.32 (+3.83%)Earnings
- Q4 2022 Liquidia Corp Earnings Call TranscriptMar 16, 2023$7.33 (+15.25%)Earnings
- Q3 2022 Liquidia Corp Earnings Call TranscriptNov 08, 2022$4.96 (+0.40%)Earnings
- Liquidia Corp Corporate Update on Hatch-Waxman Litigation Call TranscriptSep 01, 2022
- Q2 2022 Liquidia Corp Earnings Call TranscriptAug 11, 2022$5.71 (+3.07%)Earnings
- Liquidia Corp Annual Shareholders Meeting TranscriptJun 16, 2022
- Q1 2022 Liquidia Corp Earnings Call TranscriptMay 12, 2022$4.66 (-5.48%)Earnings
- Q4 2021 Liquidia Corp Earnings Call TranscriptMar 17, 2022$6.74 (+4.98%)Earnings
- Liquidia Corp Investor Conference Call to Discuss Regulatory Update TranscriptNov 08, 2021
- Q2 2021 Liquidia Corp Earnings Call TranscriptAug 10, 2021$2.41 (+1.26%)Earnings
- Liquidia Corp Annual Shareholders Meeting TranscriptJun 17, 2021
- Q1 2021 Liquidia Technologies Inc Earnings Call TranscriptMay 13, 2021$2.74Earnings
- Q4 2020 Liquidia Technologies Inc Earnings Call TranscriptMar 23, 2021$2.55 (-5.90%)Earnings
- Liquidia Technologies to Discuss Regulatory Update For LIQ861 TranscriptNov 25, 2020
- Liquidia Technologies Inc Extraordinary Shareholders Meeting TranscriptNov 13, 2020
- Q3 2020 Liquidia Technologies Inc Earnings Call TranscriptNov 09, 2020$4.52 (+0.44%)Earnings
- Q2 2020 Liquidia Technologies Inc Earnings Call TranscriptAug 10, 2020$5.91 (-4.98%)Earnings
- Liquidia Technologies Inc Update Call on Recent Announcements Regarding the Proposed Acquisition of RareGen LLC TranscriptJun 30, 2020
- Liquidia Technologies Inc Annual Shareholders Meeting TranscriptJun 18, 2020
- Q1 2020 Liquidia Technologies Inc Earnings Call TranscriptMay 11, 2020$7.43 (+9.59%)Earnings
- Q4 2019 Liquidia Technologies Inc Earnings Call TranscriptMar 11, 2020$3.66 (+2.81%)Earnings
- Q3 2019 Liquidia Technologies Inc Earnings Call TranscriptNov 13, 2019$3.72 (+8.45%)Earnings
- Q2 2019 Liquidia Technologies Inc Earnings Call TranscriptAug 08, 2019$7.31 (+9.60%)Earnings
- Q1 2019 Liquidia Technologies Inc Earnings Call TranscriptMay 02, 2019$8.85 (-8.57%)Earnings
- Q4 2018 Liquidia Technologies Inc Earnings Call TranscriptFeb 26, 2019$18.35 (-5.46%)Earnings
Liquidia Corp at Bank of America Global Healthcare Conference Transcript
May 09, 2023 / 04:35PM GMT
Release Date Price:
$7.6
Gregory Allen Harrison
BofA Securities, Research Division - Analyst
Hello, everyone. Welcome to day 1 of the Bank of America Healthcare Conference. I'm Greg Harrison, one of the Biotech Analysts here at Bank of America. And today, we have Liquidia Corporation, represented by Michael Kaseta, Chief Financial Officer. Thanks for joining us.
Michael Kaseta
Liquidia Corporation - CFO
Thanks for having me, Greg.
Gregory Allen Harrison
BofA Securities, Research Division - Analyst
Do you want to start off with maybe a quick opening remarks and then we'll jump into Q&A.
Michael Kaseta
Liquidia Corporation - CFO
Yes, that would be great. I mean, first of all, I just want to thank you for having us. It's really a great time for Liquidia. We think we're nearing the completion of our patent litigation with our competitor.
We are laser-focused on commercial readiness for launching YUTREPIA by the first half of 2024, if not earlier. And we're really excited to treat
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)